Publications by authors named "Goung-Ran Yu"

Claim this Profile
A
Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer.
Jong-Hwan Kim, Mi-Jin Lee, Goung-Ran Yu, Sang-Wook Kim, Kyu-Yun Jang, Hee-Chul Yu

Exp Mol Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
Hua Li, Jun Zhang, Mi-Jin Lee, Goung-Ran Yu, Xueji Han

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive β-catenin/BAMBI signaling.
Seok Lee, Mi-Jin Lee, Jun Zhang, Goung-Ran Yu, Dae-Ghon Kim

Exp Mol Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
Pei-Pei Hao, Hua Li, Mi-Jin Lee, Yun-Peng Wang, Jong-Hyun Kim, Goung-Ran Yu, Kyu-Yun Jang

J Hepatol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of EpCAM(+)/CD133 (-) hepatic progenitor cells.
Pei-Pei Hao, Mi-Jin Lee, Goung-Ran Yu, In-Hee Kim, Yong-Gon Cho

Mol Cells· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Yun-Peng Wang, Goung-Ran Yu, Mi-Jin Lee, Sang-Yeop Lee, In-Sun Chu

Hepatology· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor-mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis.
Xiang-Dan Cui, Mi-Jin Lee, Jong-Hyun Kim, Pei-Pei Hao, Lan Liu, Goung-Ran Yu

Hepatology· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma.
Mi-Jin Lee, Dong-Yuan Xu, Hua Li, Goung-Ran Yu, Sun-Hee Leem

Exp Mol Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.
Min-A Seol, In-Sun Chu, Mi-Jin Lee, Goung-Ran Yu, Xiang-Dan Cui, Eun-Kyung Ahn

BMC Cancer· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells.
Bo-Ra Yun, Mi-Jin Lee, Jong-Hyun Kim, In-Hee Kim, Goung-Ran Yu

Exp Mol Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma.
Xiang-Dan Cui, Mi-Jin Lee, Goung-Ran Yu, In-Hee Kim, Hee-Chul Yu

Int J Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.
Hee-Jung Yoo, Bo-Ra Yun, Jung-Hee Kwon, Hyuk-Soo Ahn, Min-A Seol, Goung-Ran Yu, Hee-Chul Yu

Exp Mol Med· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis